World's First Dengue Vaccine Now Approved In 11 Countries : ndtv

as mentioned in ndtv

World's First Dengue Vaccine Now Approved In 11 Countries

World's First Dengue Vaccine Now Approved In 11 Countries

Sanofi-Pasteur - a unit of French pharmaceutical company Sanofi - that manufactures the only approved vaccine for dengue said today that the vaccines have received approval in 11 countries.Recent approvals for Dengvaxia granted by health authorities are those from Indonesia, Thailand and Singapore.Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, have already granted it the approval."We're pleased to see the growing medical and public health recognition for the vaccine," Su Peing Ng, head of Global Medical Affairs for Sanofi Pasteur, said in a statement.


furthermore indiatimes

Not Yet In India, But The World's First Dengue Vaccine Is Approved In 11 Countries

Not Yet In India, But The World's First Dengue Vaccine Is Approved In 11 Countries

Dengue Vaccine has given a ray of hope and we are hoping that soon it gets approved in India as well.Sanofi-Pasteur, the vaccines global business unit of Sanofi, announced that the dengue vaccines have received approval in 14 countries.localpress.co.inThe countries who have approved Dengvaxia by health authorities are Mexico, The Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore.


as well bloomberg

Sanofi to Seek U.S. Approval for First Dengue Vaccine in Months

Sanofi to Seek U.S. Approval for First Dengue Vaccine in Months

Sanofi plans to seek U.S. approval for its dengue vaccine as early as this year after reaching the market in parts of Latin America and Asia where the mosquito-borne infection is widespread.The French drugmaker is focusing on the most vulnerable countries before bringing the vaccine, called Dengvaxia, to more developed regions, with a goal of getting the product on the market in about 30 nations from Malaysia to Colombia, Guillaume Leroy, dengue vice president at Sanofi's vaccines unit, said in an interview Tuesday."We are showing we can provide the vaccine to the populations who need it most," he said.